Cediranib monotherapy in patients with advanced renal cell carcinoma: Results of a randomised phase II study

Peter Mulders, Robert Hawkins, Paul Nathan, Igle De Jong, Susanne Osanto, Emilio Porfiri, Andrew Protheroe, Carla M L Van Herpen, Bijoyesh Mookerjee, Laura Pike, Juliane M. Jürgensmeier, Martin E. Gore

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'Cediranib monotherapy in patients with advanced renal cell carcinoma: Results of a randomised phase II study'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science